The World Health Organization (WHO) declared a public health emergency of international concern (PHEIC) on the resurgence of monkeypox after the 2022–2023 epidemic, a zoonotic ailment with primary reservoirs in rodents and non-human primates, that also has the potential for reverse zoonosis [1]. The virus has two genetic clades: one in Central Africa (clade I) and the other in West Africa (clade II) [2]. In 2022, MPXV clade IIb triggered an unprecedented global disease outbreak that affected approximately 90,000 people across six continents (Fig.
